MA02.02 Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer

Title
MA02.02 Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer
Authors
Keywords
-
Journal
Journal of Thoracic Oncology
Volume 16, Issue 10, Pages S889-S890
Publisher
Elsevier BV
Online
2021-10-20
DOI
10.1016/j.jtho.2021.08.112

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started